Lieven Pouillon , Anne Lamoureux , Guillaume Pineton de Chambrun , Lucine Vuitton , Benjamin Pariente , Camille Zallot , Gaspard Dufour , Mathurin Fumery , Cédric Baumann , Aurélien Amiot , Stéphane Nancey…
Lire la suite
2019
Dose De-Escalation to Adalimumab 40 Mg Every Three Weeks in Patients With Inflammatory Bowel disease-A Multicenter, Retrospective, Observational Study
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D (Clin Gastroenterol Hepatol.…
Lire la suite
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.
Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G,…
Lire la suite
Adalimumab for Patients With Crohn’s Disease Complicated by Intra-Abdominal Abscess: A Multicentre, Prospective, Observational Cohort Study
G Pineton de Chambrun , B Pariente , P Seksik , R Altwegg , L Vuitton , C Stefasnescu , S Nancey , A Aubourg , M Serrero , L Peyrin-Biroulet , J Filippi…
Lire la suite